Artelo Biosciences Inc

NASDAQ:ARTL

1.32

+0.04 (+2.73%)

7:20:03 PM EDT: $1.31 -0.01 (-0.38%)

Artelo Biosciences Inc Stock, NASDAQ:ARTL

505 Lomas Santa Fe, Suite 160, Solana Beach, California 92075

United States of America

Phone: +1.858.925.7049

Number of Employees: 6

http://www.artelobio.com

Description

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.